4 ms·
The paper addresses that question briefly: It is unclear whether this antibody reactivity may confer clinical benefits, for instance, modulating
by maxerickson 6y ago
The paper addresses that question briefly:
It is unclear whether this antibody reactivity may confer clinical benefits, for instance, modulating the severity of a SARS-CoV-2 infection.
I think quantifying any protective effect is gonna be pretty difficult.
- Animats 6y agoRight. What this seems to be saying is that, for one tiny area of Vancover, BC, 90% of the people tested with a very sensitive antibody test showed that their immune system had encountered some relevant coronavirus and had reacted to it. Is that right? The trouble is that the article has a clickbait title: "A majority of uninfected adults show pre-existing antibody reactivity against SARS-CoV-2". Which may get translated into "We already have herd immunity" by some television pundit shortly.
- SpicyLemonZest 6y agoIs it clickbait? It's a journal article, and as far as I can tell "antibody reactivity" is the correct technical term for what they're describing. Certainly some pundits will misinterpret it, but I don't think we can expect researchers to shape everything they write to avoid PR misunderstandings.
- throwawayfrauds 6y agoI’d say that everything about this article is the opposite of clickbait. It’s not buzzfeed, it’s a science journal.